Dose Insider / Outsourcing pharmacies / Nivagen Pharmaceuticals, LLC

Nivagen Pharmaceuticals, LLCFDA registration and inspection record

FDA list of November 17, 2026 · checked against fda.gov on November 20, 2026

Nivagen Pharmaceuticals, LLC in Sacramento, California is registered with FDA as a 503B outsourcing facility, first on March 13, 2026 and most recently on October 16, 2026. FDA has not yet inspected it as an outsourcing facility.

Not yet inspectedregistered with FDA since March 13, 2026
Facilities registered, by first yearFDA list of November 17, 2026; this facility’s year in coral20196202032021120224202392024152025142026, this one14Facilities registered, byfirst yearFDA list of November 17, 2026; this facility’syear in coral20196202032021120224202392024152025142026, this one14

From FDA’s list of registered outsourcing facilities, November 17, 2026.

On this page

These facts come from FDA’s list of registered outsourcing facilities, updated November 17, 2026, and from the inspection report FDA posted with it.1 None of the 164 FDA warning letters about GLP-1 drugs in our database names this company.

What does FDA’s record show, in brief?

FacilityNivagen Pharmaceuticals, LLC
LocationSacramento, California
Type503B outsourcing facility
Registered sinceMarch 13, 2026
Latest registrationOctober 16, 2026
Last FDA inspectionNot yet inspected
Inspection dates—
Form 483Not issued
FDA action after the inspectionNone listed
Compounds sterile drugs from bulkYes
FDA warning letters on GLP-1 drugs0

Has this facility recalled any drugs?

FDA’s enforcement reports list 1 recalled product from this facility, from September 24, 2024 to September 24, 2024: 1 in Class II. None of them names a GLP-1 drug. Class I is the most serious: FDA uses it when the product could cause serious harm.3

StartedClassProductReason
2024-09-24IIAtorvastatin Calcium TabletsPresence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of…

Is the pharmacy behind my prescription on FDA’s list?

Type a pharmacy name or city. The search runs over all 100 facilities on FDA’s list; a 503A pharmacy that compounds for individual prescriptions is licensed by its state and is not on this list.

Pharmacy check100 facilities
Registered 503B—
With a Form 483—

Where are the registered outsourcing facilities?

8 of the 100 facilities on FDA’s list are in California. The chart counts them by state; choose a view to see which ones FDA has inspected.

Facilities by stateFDA list, November 17, 2026
Show
Facilities—
Top state—

Which other facilities are in the same state?

What does it mean that a pharmacy is a 503B outsourcing facility?

An outsourcing facility is a compounder that has chosen to register with FDA under section 503B of the Federal Food, Drug, and Cosmetic Act. It must re-register every year between October 1 and December 31 and pay an annual fee; a facility that does not is removed from FDA’s list on January 1.1 Once registered, it joins the list of facilities FDA plans to inspect on a risk-based schedule.1

A Form FDA 483 lists what investigators observed during an inspection. FDA states that a 483 is issued when investigators see significant objectionable conditions, and that it is not a final agency determination that the law was broken.1 Registration is not FDA approval of the drugs a facility makes: compounded drugs are not FDA-approved.

Sources

  1. FDA. Facilities registered as human drug compounding outsourcing facilities under section 503B, updated November 17, 2026, with its notes on registration and inspections. fda.gov
  2. FDA. Registered outsourcing facilities: inspection status of Nivagen Pharmaceuticals, LLC. fda.gov
  3. FDA. Drug recall enforcement reports for Nivagen Pharmaceuticals, LLC, read through openFDA on November 20, 2026. open.fda.gov

Log every dose in mg with the vial it came from, so there is a record if something goes wrong.

Open Dose Insider